| Trial Identifier: | D5136C00008 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02482298 |
| Start Date: | July 2015 |
| Primary Completion Date: | November 2016 |
| Study Completion Date: | November 2016 |
| Condition: | Heart, Blood & Circulatory - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English translation | |
| Arabic translation | |
| Dholou translation | |
| French translation | |
| Italian translation | |
| Turkish translation | |
| Swahili translation | |
| English translation |
| Country | Location |
|---|---|
| Egypt | Alexandria, Egypt, 21131 |
| Egypt | Cairo, Egypt, 11562 |
| Egypt | Cairo, Egypt, 11566 |
| France | Bordeaux Cedex, France, 33076 |
| France | Strasbourg, France, 67091 |
| Italy | Verona, Italy, 37134 |
| Kenya | Kikuyu, Kenya, 00100 |
| Kenya | Kisian, Kenya, 40100 |
| Kenya | Nairobi, Kenya, 40100 |
| Lebanon | Beirut, Lebanon, 113-6044 |
| Lebanon | Beirut, Lebanon, 1107 2020 |
| Turkey | Adana, Turkey, 01130 |
| Turkey | Mersin, Turkey, 33079 |
| Turkey | Van, Turkey, 65080 |
| United Kingdom | Harrow, United Kingdom, HA1 3UJ |
| United Kingdom | London, United Kingdom, E9 6SR |
| United Kingdom | LONDON, United Kingdom, E1 1BB |
| United States of America, MD | Bethesda, MD, United States of America, 20817 |
| United States of America, SC | Charleston, SC, United States of America, 29425 |